[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@AM231982 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1014974088618659840.png) @AM231982 AM23

AM23 posts on X about cracked, halflife, $8750t, $4568t the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours.

### Engagements: undefined [#](/creator/twitter::1014974088618659840/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1014974088618659840/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX +10%
- X Year XXXXXX -XX%

### Mentions: undefined [#](/creator/twitter::1014974088618659840/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1014974088618659840/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::1014974088618659840/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1014974088618659840/c:line/m:followers.svg)

- X Week XXX -XXXX%
- X Month XXX -XXXX%
- X Months XXX +56%
- X Year XXX +20%

### CreatorRank: undefined [#](/creator/twitter::1014974088618659840/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1014974088618659840/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1014974088618659840/influence)
---

**Social topic influence**
[cracked](/topic/cracked), [halflife](/topic/halflife), [$8750t](/topic/$8750t), [$4568t](/topic/$4568t), [$6417t](/topic/$6417t), [$112bn](/topic/$112bn)
### Top Social Posts [#](/creator/twitter::1014974088618659840/posts)
---
Top posts by engagements in the last XX hours

"We already know Avacta have cracked the half-life limitation and increased it to over 60+ hours (note the comment on the next page referencing a typical X hours They have also increased the therapeutic index window by 75X. We are not done yet.They dosed 50mg/kg with 'NO TOXICITY NOTED' If this doesn't wipe the floor with Pharma's best efforts on Exatecan derivatives I will be astounded. Think Nokia 6310 to latest iPhone and you get to miss out everything in between. It is that significant. (3/5)"  
[X Link](https://x.com/AM231982/status/1975852731551125831) [@AM231982](/creator/x/AM231982) 2025-10-08T09:16Z XXX followers, XXX engagements


"Daiichi Sankyo dosed over 1000 patients with Exatecan in clinical trials but ultimately it failed in the clinic. Today they use Deruxtecan (basically a watered down version of Exatecan) in their blockbuster ADC drug Enhertu Enhertu is expected to generate $11.2bn by 2030 per year. Imagine what AVA6103 could do with a much wider total addressable market (TAM) vs Enhertu which is limited by HER2 expression. Avacta's PreCISION uses FAP which is fortunately present in XX% of solid tumours (4/5)"  
[X Link](https://x.com/AM231982/status/1975852734940131810) [@AM231982](/creator/x/AM231982) 2025-10-08T09:16Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@AM231982 AM23

AM23 posts on X about cracked, halflife, $8750t, $4568t the most. They currently have XXX followers and XX posts still getting attention that total X engagements in the last XX hours.

Engagements: undefined #

X Week XXX -XX%
X Month XXXXX -XX%
X Months XXXXXX +10%
X Year XXXXXX -XX%

Mentions: undefined #

Followers: XXX #

X Week XXX -XXXX%
X Month XXX -XXXX%
X Months XXX +56%
X Year XXX +20%

CreatorRank: undefined #

Social Influence #

Social topic influence cracked, halflife, $8750t, $4568t, $6417t, $112bn

Top Social Posts #

Top posts by engagements in the last XX hours

"We already know Avacta have cracked the half-life limitation and increased it to over 60+ hours (note the comment on the next page referencing a typical X hours They have also increased the therapeutic index window by 75X. We are not done yet.They dosed 50mg/kg with 'NO TOXICITY NOTED' If this doesn't wipe the floor with Pharma's best efforts on Exatecan derivatives I will be astounded. Think Nokia 6310 to latest iPhone and you get to miss out everything in between. It is that significant. (3/5)"
X Link @AM231982 2025-10-08T09:16Z XXX followers, XXX engagements

"Daiichi Sankyo dosed over 1000 patients with Exatecan in clinical trials but ultimately it failed in the clinic. Today they use Deruxtecan (basically a watered down version of Exatecan) in their blockbuster ADC drug Enhertu Enhertu is expected to generate $11.2bn by 2030 per year. Imagine what AVA6103 could do with a much wider total addressable market (TAM) vs Enhertu which is limited by HER2 expression. Avacta's PreCISION uses FAP which is fortunately present in XX% of solid tumours (4/5)"
X Link @AM231982 2025-10-08T09:16Z XXX followers, XXX engagements